机构：[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China四川大学华西医院[2]Department of Rehabilitation, Southwest Medical University Hospital, Luzhou, China.
This research was funded by Chinese Scholarship
Council (grant no. 202206240086).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2024]版：
无
最新[2023]版：
大类|1 区医学
小类|1 区泌尿学与肾脏学
第一作者：
第一作者机构：[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China[2]Department of Rehabilitation, Southwest Medical University Hospital, Luzhou, China.[*1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China.
共同第一作者：
通讯作者：
通讯机构：[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China[2]Department of Rehabilitation, Southwest Medical University Hospital, Luzhou, China.[*1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China.
推荐引用方式(GB/T 7714)：
Feng Dechao,Wang Jie,Wu Ruicheng,et al.Re: Immune System and Intestinal Microbiota Determine Efficacy of Androgen Deprivation Therapy Against Prostate Cancer[J].European Urology.2024,doi:10.1016/j.eururo.2024.01.025.
APA：
Feng Dechao,Wang Jie,Wu Ruicheng&Li Dengxiong.(2024).Re: Immune System and Intestinal Microbiota Determine Efficacy of Androgen Deprivation Therapy Against Prostate Cancer.European Urology,,
MLA：
Feng Dechao,et al."Re: Immune System and Intestinal Microbiota Determine Efficacy of Androgen Deprivation Therapy Against Prostate Cancer".European Urology .(2024)
医学